Amy Pakyz
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 29
-
- Nosocomial Infections in ICU 8
- Co-authors
- Ronald E. PolkMichael OinonenConan MacDougallMichael B. EdmondMichael StevensSpencer E. HarpeLeticia R. MoczygembaLisa L. Dwyer
- Journals
- Infection Control and Hospital Epidemiology (11 papers)American Journal of Infection Control (10 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (5 papers)Current Infectious Disease Reports (3 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Amy Pakyz
58 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 89
- Applied Microbiology and Biotechnology 543
- Molecular Medicine 171
- Critical Care and Intensive Care Medicine 158
- Clinical Biochemistry 179
- Infectious Diseases 370
Countries citing papers authored by Amy Pakyz
This map shows the geographic impact of Amy Pakyz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Pakyz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Pakyz more than expected).
Fields of papers citing papers by Amy Pakyz
This network shows the impact of papers produced by Amy Pakyz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Pakyz. The network helps show where Amy Pakyz may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Pakyz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 3 | |
| 2 | 2019 | 28 | |
| 3 | 2019 | 3 | |
| 4 | 2019 | 6 | |
| 5 | 2019 | 4 | |
| 6 | 2018 | 24 | |
| 7 | 2018 | 2 | |
| 8 | 2018 | 5 | |
| 9 | Impact of health reform on young adult prescription medication utilization. | 2017 | 1 |
| 10 | 2017 | 5 | |
| 11 | 2017 | 3 | |
| 12 | 2015 | 7 | |
| 13 | 2014 | 84 | |
| 14 | 2013 | 42 | |
| 15 | 2011 | 29 | |
| 16 | 2010 | 42 | |
| 17 | 2009 | 7 | |
| 18 | 2009 | 47 | |
| 19 | 2008 | 140 | |
| 20 | 2000 | 32 |
About Amy Pakyz
Amy Pakyz is a scholar working on Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Infectious Diseases, Clinical Biochemistry and General Health Professions, having authored 61 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (29 papers), Patient Satisfaction in Healthcare (14 papers), Clostridium difficile and Clostridium perfringens research (14 papers), Microscopic Colitis (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Nosocomial Infections in ICU (8 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (543 citations), Molecular Medicine (171 citations), Critical Care and Intensive Care Medicine (158 citations), Clinical Biochemistry (179 citations) and Infectious Diseases (370 citations). Amy Pakyz has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Ronald E. Polk, Michael Oinonen, Conan MacDougall, Michael B. Edmond, Michael Stevens, Spencer E. Harpe, Leticia R. Moczygemba, Lisa L. Dwyer, Kate L. Lapane and Lynn M. VanderWielen. Their work appears in journals such as Infection Control and Hospital Epidemiology, American Journal of Infection Control, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Current Infectious Disease Reports and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.